Through linking test results to electronic health records in England from 1995 to 2019, researchers estimated relative and absolute second primary cancer risks for BRCA1/2 carriers after breast cancer.
This study gives us more generalizable information about cancer risks in BRCA carriers, which can help guide risk assessment and management.
Read the full article to learn more at: https://ascopubs.org/doi/10.1200/JCO.24.01146
Reference: Allen, et al. J Clin Oncol. 2024:JCO2401146. PMID: 39475295.